{
    "Trade/Device Name(s)": [
        "SYNCHRON Systems Enzymatic Creatinine (CR-E) Reagent"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K093458",
    "Predicate Device Reference 510(k) Number(s)": [
        "K091742"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JFY"
    ],
    "Summary Letter Date": "November 4, 2009",
    "Summary Letter Received Date": "November 6, 2009",
    "Submission Date": "November 4, 2009",
    "Regulation Number(s)": [
        "21CFR862.1225"
    ],
    "Regulation Name(s)": [
        "Creatinine Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Creatinine"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "SYNCHRON LX",
        "UniCel DxC 600/800",
        "SYNCHRON PRO Clinical Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic method",
        "Photometric end-point reaction"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for SYNCHRON Systems Enzymatic Creatinine (CR-E) Reagent for quantitative creatinine measurement in serum, plasma, or urine using enzymatic-photometric method.",
    "Indications for Use Summary": "Quantitative determination of creatinine concentration in human serum, plasma, or urine (urine not available on SYNCHRON PRO Systems) to aid in diagnosis and treatment of renal diseases, monitor renal dialysis, and as a calculation basis for other urine analytes.",
    "fda_folder": "Clinical Chemistry"
}